In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: Correlation with hepatic steatosis

Journal of Gastroenterology

Volumn 40, Issue 6, 2005, Pages 617-624

  Kitase, Akira ^a   Hino, Keisuke ^a   Furutani, Takakazu ^a   Okuda, Michiari ^a   Gondo, Toshikazu ^b   Hidaka, Isao ^a   Hara, Yuichi ^a   Yamaguchi, Yuhki ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

4 hydroxy 2 hexenal; Lipid peroxidation; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; MALONALDEHYDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CORRELATION FUNCTION; FATTY ACID ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID COMPOSITION; LIPID PEROXIDATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ALDEHYDES; BIOLOGICAL MARKERS; BIOPSY; CHROMATOGRAPHY, GAS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 22844447076     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-005-1596-x     Document Type: Article

References (32)

1. N Bach SN Thung F Schaffner 1992 The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis Hepatology 15 572-7 1551632
2. PJ Scheuer P Ashrafzadeh S Sherlock D Brown GM Dusheiko 1992 The pathology of hepatitis C Hepatology 15 567-71 1551631
3. JH Lefkowitch ER Schiff GL Davis RP Perrillo K Lindsay HC Bodenheimer Jr et al 1993 Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group Gastroenterology 104 595-603 8425703
4. G Barba F Harper T Harada M Kohara S Goulinet Y Matsuura et al 1997 Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets Proc Natl Acad Sci USA 94 1200-5 9037030
5. K Moriya H Yotsuyanagi Y Shintani H Fujie K Ishibashi Y Matsuura et al 1997 Hepatitis C virus core protein induces hepatic steatosis in transgenic mice J Gen Virol 78 1527-31 9225025
6. K Moriya H Fujie Y Shintani H Yotsuyanagi T Tsutsumi K Ishibashi 1998 The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat Med 4 1065-7 9734402
7. H Lerat M Honda MR Beard K Loesch J Sun Y Yang et al 2002 Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus Gastroenterology 122 352-65 11832450
8. L Rubbia-Brandt R Quadri K Abid E Giostra PJ Male G Mentha et al 2000 Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 J Hepatol 33 106-15 10905593
9. JM Hui J Kench GC Farrell R Lin D Samarasinghe C Liddle et al. 2002 Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection J Gastroenterol Hepatol 17 873-81 12164963
10. D Kumar GC Farrell C Fung J George C Hepatitis 2002 virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response Hepatology 36 1266-72 12395339
11. T Poynard V Ratziu J McHutchison M Manns Z Goodman S Zeuzem et al 2003 Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C Hepatology 38 75-85 12829989
12. LE Adinolfi M Gambardella A Andreana MF Tripodi R Utili G Ruggiero 2001 Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 1358-64 11391523
13. K Ohata K Hamasaki K Toriyama K Matsumoto A Saeki K Yanagi et al 2003 Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection Cancer 97 3036-43 12784339
14. AW Girotti 1998 Lipid hydroperoxide generation, turnover, and effector action in biological systems J Lipid Res 39 1529-42 9717713
15. P Letteron B Fromenty B Terris C Degott D Pessayre 1996 Acute and chronic hepatic steatosis leads to in vivo lipid peroxidation in mice J Hepatol 24 200-8 8907574
16. F Farinati R Cardin N De Maria G Della Libera C Marafin E Lecis et al. 1995 Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis J Hepatol 22 449-56 7545199
17. V Paradis P Mathurin M Kollinger F Imbert-Bismut F Charlotte A Piton et al. 1997 In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features J Cin Pathol 50 401-6
18. F Kageyama Y Kobayashi T Kawasaki S Toyokuni K Uchida H Nakamura et al. 2000 Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C Am J Gastroenterol 95 1041-50 10763957
19. G Perlemuter P Letteron F Carnot F Zavala D Pessayre B Nalpas et al. 2003 Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model J Hepatol 39 1020-7 14642621
20. KH Cheeseman 1993 Mechanisms and effects of lipid peroxidation Mol Aspects Med 14 191-7 8264333
21. H Esterbauer RJ Schaur H Zollner 1991 Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic Biol Med 11 81-128 1937131
22. S Yamada T Funada N Shibata M Kobayashi Y Kawai E Tatsuda et al. 2004 Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids J Lipid Res 45 626-34 14729859
23. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer 1994 Classification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1513-20 8188183
24. M Hilden P Christoffersen E Juhl JB Dalgaard 1977 Liver histology in a "normal" population-examinations of 503 consecutive fatal traffic casualties Scand J Gastroenterol 12 593-7 918553
25. AD Burt A Mutton CP Day 1998 Diagnosis and interpretation of steatosis and steatohepatitis Semin Diagn Pathol 15 246-58 9845426
26. EM Brunt 2004 Nonalcoholic steatohepatitis Semin Liver Dis 24 3-20
27. EG Bligh WJ Dyer 1959 A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 911-7 1:CAS:528:DyaG1MXhtVSgt70%3D 13671378
28. M Okita M Hayashi T Sasagawa K Takagi K Suzuki S Kinoyama et al. 2001 Effect of a moderately energy-restricted diet on obese patients with fatty liver Nutrition 17 542-7 11448571
29. G Perlemuter A Sabile P Letteron G Vona A Topilco Y Chretien et al. 2002 Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: A model of viral-related steatosis FASEB J 16 185-94 11818366
30. AJ Czaja HA Carpenter PJ Santrach SB Moore 1998 Host- and disease-specific factors affecting steatosis in chronic hepatitis C J Hepatol 29 198-206 9722200
31. A Monto J Alonzo JJ Watson C Grunfeld TL Wright 2002 Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol Hepatology 36 729-36 12198667
32. CP Day OFW James 1998 Steatohepatitis: A tale of two "hits"? Gastroenterology 114 842-5 9547102